Organization and Description of Business - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Cash	$ 15,740	$ 40,566
Accumulated deficit	(111,503)	(71,743)
Net loss	(39,760)	(40,335)
Net cash used in operating activities	28,930	$ 30,818
Direct medical costs, annually	$ 100,000,000